Iqvia Government Solutions Inc.

Iqvia Government Solutions Inc., a for-profit subsidiary of Iqvia Inc. based in Falls Church, Virginia, provides healthcare data, analytics, and clinical research services to federal agencies as a prime contractor (94% of recent awards) competing on a full-and-open basis across its federal portfolio. The company does not hold SBA set-aside certifications and operates across multiple NAICS categories, with primary concentrations in Other Computer Related Services (64 awards), Computing Infrastructure Providers and Data Processing (60 awards), and All Other Professional, Scientific, and Technical Services (45 awards).

Iqvia Government Solutions' customer concentration is heavily weighted toward the health sector. The top five customer agencies account for 51% of awards by count, led by the Department of Health and Human Services Food and Drug Administration (65 awards, $546.6 million combined potential value), CDC Pittsburgh (36 awards, $99.6 million), CMS (13 awards, $136.4 million), the Office of the Assistant Secretary for Administration (12 awards, $519.1 million), and the Defense Health Agency (11 awards, $35.03 billion combined potential value). The potential-value ranking reveals a structural outlier: the Defense Health Agency's eleven awards carry $35.03 billion in combined potential value, anchoring the vendor's dollar concentration despite relatively modest award count — a signal of large-value vehicle positions. By contrast, FDA's 65 awards aggregate to $546.6 million, reflecting numerous smaller task orders against multiple IDCs. Recent prime work includes a $24.4 million CDC pharmacy data definitive contract awarded September 2024, an $11.97 million CDC Health Data Engine program definitive contract (September 2024), an $11.1 million DEA prescription data collection contract running through July 2030 (August 2025), a $34.06 million CMS delivery order for prescription drug data and information purchases via GSA MAS (January 2025), and a $4.46 million FDA hospital inpatient and emergency department drug utilization data delivery order (July 2025).

Iqvia Government Solutions holds multiple parent vehicles anchoring its federal delivery. The Chief Information Officer Commodities and Solutions (CIO-CS) GWAC carries 32 task orders worth $41.4 million combined potential value; Federal Supply Schedule GS35F0763M carries 19 task orders worth $53.3 million; Indefinite Delivery Contract FA701406A3001 carries 14 task orders worth $21.6 million; and Federal Supply Schedule GS35F0083T carries 7 task orders worth $11.2 million. The vendor also holds three prime IDCs with FDA: an $75 million multiple-award IDC for the Biologics Effectiveness and Safety (BEST) Initiative #3 (awarded September 2024, running through September 2029); a $16.8 million single-award IDC for outpatient longitudinal drug utilization data (awarded August 2025, running through August 2027); and a $4.46 million single-award IDC for hospital inpatient and emergency department drug utilization data (awarded July 2025, running through July 2030). These vehicles position the company to field task orders across civilian health and defense health agencies for prescription data, drug safety surveillance, analytics platforms, and software solutions.

Award activity has remained relatively stable year over year — 13 awards in 2022, 15 in 2023, and 16 in 2024 — with 9 awards (combined potential value $55.4 million) reaching completion inside the next twenty-four months and facing recompete. SCI-reported invoicing on federal service contracts above the $150,000 threshold ran $70.3 million across FY2022–FY2024 (FY2022: $23.1 million; FY2023: $21.6 million; FY2024: $25.6 million), with FTE headcount ranging from 5.0 to 20.9 FTEs across reporting years — a volatility signal reflecting the episodic nature of task orders under large vehicle ceilings. On federal services contracts captured in SCI, government-paid median hourly rates ran around $3,908/hr, with a 10th percentile of $314.78/hr and 90th percentile of $24,941.56/hr, indicating a pricing spectrum spanning data-support and analyst labor through senior subject-matter expertise and executive consultation.

Iqvia Government Solutions operates primarily as an in-house delivery vehicle with minimal subcontractor engagement. Across SCI-reportable prime contracts, an average of 5% of contractor hours were performed by named subcontractors, with 9 total named subs reported across the dataset. In its subcontractor role, the vendor delivers vaccine program evaluation, clinical trial support, and epidemiological data science services to primes including Dynport Vaccine Company LLC (Phase 1 services, August 2024), Takeda Vaccines Inc. (clinical trial support across multiple option periods), Hendall Inc. (Program Evaluations for Prevention Contract, April 2024), Vista Defense Technologies LLC (Observational Medical Outcomes Partnership Data Science support, September 2023), and Management Sciences for Health Inc. (Medicines, Technologies, and Pharmaceutical Services support to USAID low- and middle-income countries, June 2022 through April 2023). Sub-award work spans vaccine development, medicines access programming in developing countries, and observational clinical data science — roles complementary to the parent vendor's core healthcare data and analytics capabilities but not central to its federal footprint.